Dr. Rafael Davalos, one of our inventors at Virginia Tech (VT), found that with currently existing technologies, he was unable to separate different kinds of cancer cells found in tumors. He was particularly interested in cancer stem cells (CSCs) which can be responsible for cancer recurrence. So he set about inventing a new technology that can rapidly sort and recover different cell types, including CSCs, to investigate disease understanding, therapy selections, and drug development. Mr. Leo Harris, a VT alum, came on as a co-founder, and their partnership laid the foundation for CytoRecovery. Since then, the expanding team has been prototyping and building our commercial-grade product system.

We are bringing to market advanced microfluidic technology to enable cell biologists and other life science researchers to rapidly sort, enrich, and recover rare, homogeneous, viable cell subpopulations from tissue, blood and other biological samples. Our exclusively licensed technologies were invented at Virginia Tech and the University of Virginia, bringing together a cross-commonwealth collaboration.